APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gases for Pharmaceutical and Biotechnology

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gases for Pharmaceutical and Biotechnology Market Outlook and Growth Opportunities 2026

27 December 2025198 pages

Choose your research edition.

Industry ResearchGases for Pharmaceutical and Biotechnology Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Gases for Pharmaceutical and Biotechnology Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Gases for Pharmaceutical and Biotechnology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gases for Pharmaceutical and Biotechnology Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Gases for Pharmaceutical and Biotechnology Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Gases for Pharmaceutical and Biotechnology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gases for Pharmaceutical and Biotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gases for Pharmaceutical and Biotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gases for Pharmaceutical and Biotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gases for Pharmaceutical and Biotechnology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gases for Pharmaceutical and Biotechnology market include Air Liquide, Taiyo Nippon Sanso, Messer Group, Matheson, Air Products, Coregas, Linde and SOL Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gases for Pharmaceutical and Biotechnology market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gases for Pharmaceutical and Biotechnology and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gases for Pharmaceutical and Biotechnology sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gases for Pharmaceutical and Biotechnology market size, projected growth trends, production technologies, key applications, and end-use industries.

Gases for Pharmaceutical and Biotechnology Segment by Company

Air Liquide

Taiyo Nippon Sanso

Messer Group

Matheson

Air Products

Coregas

Linde

SOL Group

Gases for Pharmaceutical and Biotechnology Segment by Type

Nitrogen

Carbon Dioxide

Oxygen

Others

Gases for Pharmaceutical and Biotechnology Segment by Application

Laboratory

Pharmaceutical and Biotechnology Companies

Others

Gases for Pharmaceutical and Biotechnology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gases for Pharmaceutical and Biotechnology status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gases for Pharmaceutical and Biotechnology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gases for Pharmaceutical and Biotechnology significant trends, drivers, influence factors in global and regions.

6. To analyze Gases for Pharmaceutical and Biotechnology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gases for Pharmaceutical and Biotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gases for Pharmaceutical and Biotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gases for Pharmaceutical and Biotechnology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gases for Pharmaceutical and Biotechnology market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gases for Pharmaceutical and Biotechnology industry.

Chapter 3: Detailed analysis of Gases for Pharmaceutical and Biotechnology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gases for Pharmaceutical and Biotechnology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gases for Pharmaceutical and Biotechnology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gases for Pharmaceutical and Biotechnology Industry Trends Table 2. Gases for Pharmaceutical and Biotechnology Industry Drivers Table 3. Gases for Pharmaceutical and Biotechnology Industry Opportunities and Challenges Table 4. Gases for Pharmaceutical and Biotechnology Industry Restraints Table 5. Global Gases for Pharmaceutical and Biotechnology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gases for Pharmaceutical and Biotechnology Revenue Share by Company (2021-2026) Table 7. Global Gases for Pharmaceutical and Biotechnology Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Gases for Pharmaceutical and Biotechnology Sales Volume Share by Company (2021-2026) Table 9. Global Gases for Pharmaceutical and Biotechnology Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Gases for Pharmaceutical and Biotechnology Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gases for Pharmaceutical and Biotechnology Key Company Manufacturing Base & Headquarters Table 12. Global Gases for Pharmaceutical and Biotechnology Company, Product Type & Application Table 13. Global Gases for Pharmaceutical and Biotechnology Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gases for Pharmaceutical and Biotechnology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nitrogen Table 18. Significant Companies of Carbon Dioxide Table 19. Significant Companies of Oxygen Table 20. Significant Companies of Others Table 21. Global Gases for Pharmaceutical and Biotechnology Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 22. Global Gases for Pharmaceutical and Biotechnology Sales Volume by Type (2021-2026) & (Tons) Table 23. Global Gases for Pharmaceutical and Biotechnology Sales Volume by Type (2027-2032) & (Tons) Table 24. Global Gases for Pharmaceutical and Biotechnology Sales Volume Share by Type (2021-2026) Table 25. Global Gases for Pharmaceutical and Biotechnology Sales Volume Share by Type (2027-2032) Table 26. Global Gases for Pharmaceutical and Biotechnology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Gases for Pharmaceutical and Biotechnology Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Gases for Pharmaceutical and Biotechnology Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type (2021-2026) Table 30. Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Laboratory Table 32. Significant Companies of Pharmaceutical and Biotechnology Companies Table 33. Significant Companies of Others Table 34. Global Gases for Pharmaceutical and Biotechnology Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 35. Global Gases for Pharmaceutical and Biotechnology Sales Volume by Application (2021-2026) & (Tons) Table 36. Global Gases for Pharmaceutical and Biotechnology Sales Volume by Application (2027-2032) & (Tons) Table 37. Global Gases for Pharmaceutical and Biotechnology Sales Volume Share by Application (2021-2026) Table 38. Global Gases for Pharmaceutical and Biotechnology Sales Volume Share by Application (2027-2032) Table 39. Global Gases for Pharmaceutical and Biotechnology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Gases for Pharmaceutical and Biotechnology Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Gases for Pharmaceutical and Biotechnology Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application (2021-2026) Table 43. Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application (2027-2032) Table 44. Global Gases for Pharmaceutical and Biotechnology Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 45. Global Gases for Pharmaceutical and Biotechnology Sales by Region (2021-2026) & (Tons) Table 46. Global Gases for Pharmaceutical and Biotechnology Sales Market Share by Region (2021-2026) Table 47. Global Gases for Pharmaceutical and Biotechnology Sales by Region (2027-2032) & (Tons) Table 48. Global Gases for Pharmaceutical and Biotechnology Sales Market Share by Region (2027-2032) Table 49. Global Gases for Pharmaceutical and Biotechnology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Gases for Pharmaceutical and Biotechnology Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Region (2021-2026) Table 52. Global Gases for Pharmaceutical and Biotechnology Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Region (2027-2032) Table 54. Global Gases for Pharmaceutical and Biotechnology Market Average Price (US$/Ton) by Region (2021-2026) Table 55. Global Gases for Pharmaceutical and Biotechnology Market Average Price (US$/Ton) by Region (2027-2032) Table 56. Global Gases for Pharmaceutical and Biotechnology Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 57. Global Gases for Pharmaceutical and Biotechnology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Gases for Pharmaceutical and Biotechnology Sales by Country (2021-2026) & (Tons) Table 59. Global Gases for Pharmaceutical and Biotechnology Sales Market Share by Country (2021-2026) Table 60. Global Gases for Pharmaceutical and Biotechnology Sales by Country (2027-2032) & (Tons) Table 61. Global Gases for Pharmaceutical and Biotechnology Sales Market Share by Country (2027-2032) Table 62. Global Gases for Pharmaceutical and Biotechnology Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Gases for Pharmaceutical and Biotechnology Sales Value Market Share by Country (2021-2026) Table 64. Global Gases for Pharmaceutical and Biotechnology Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Gases for Pharmaceutical and Biotechnology Sales Value Market Share by Country (2027-2032) Table 66. Air Liquide Company Information Table 67. Air Liquide Business Overview Table 68. Air Liquide Gases for Pharmaceutical and Biotechnology Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. Air Liquide Gases for Pharmaceutical and Biotechnology Product Portfolio Table 70. Air Liquide Recent Development Table 71. Taiyo Nippon Sanso Company Information Table 72. Taiyo Nippon Sanso Business Overview Table 73. Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Product Portfolio Table 75. Taiyo Nippon Sanso Recent Development Table 76. Messer Group Company Information Table 77. Messer Group Business Overview Table 78. Messer Group Gases for Pharmaceutical and Biotechnology Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Messer Group Gases for Pharmaceutical and Biotechnology Product Portfolio Table 80. Messer Group Recent Development Table 81. Matheson Company Information Table 82. Matheson Business Overview Table 83. Matheson Gases for Pharmaceutical and Biotechnology Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Matheson Gases for Pharmaceutical and Biotechnology Product Portfolio Table 85. Matheson Recent Development Table 86. Air Products Company Information Table 87. Air Products Business Overview Table 88. Air Products Gases for Pharmaceutical and Biotechnology Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Air Products Gases for Pharmaceutical and Biotechnology Product Portfolio Table 90. Air Products Recent Development Table 91. Coregas Company Information Table 92. Coregas Business Overview Table 93. Coregas Gases for Pharmaceutical and Biotechnology Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Coregas Gases for Pharmaceutical and Biotechnology Product Portfolio Table 95. Coregas Recent Development Table 96. Linde Company Information Table 97. Linde Business Overview Table 98. Linde Gases for Pharmaceutical and Biotechnology Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Linde Gases for Pharmaceutical and Biotechnology Product Portfolio Table 100. Linde Recent Development Table 101. SOL Group Company Information Table 102. SOL Group Business Overview Table 103. SOL Group Gases for Pharmaceutical and Biotechnology Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. SOL Group Gases for Pharmaceutical and Biotechnology Product Portfolio Table 105. SOL Group Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Gases for Pharmaceutical and Biotechnology Distributors List Table 109. Gases for Pharmaceutical and Biotechnology Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Gases for Pharmaceutical and Biotechnology Product Image Figure 2. Global Gases for Pharmaceutical and Biotechnology Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gases for Pharmaceutical and Biotechnology Sales (2021-2032) & (Tons) Figure 5. Global Gases for Pharmaceutical and Biotechnology Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Gases for Pharmaceutical and Biotechnology Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nitrogen Image Figure 10. Carbon Dioxide Image Figure 11. Oxygen Image Figure 12. Others Image Figure 13. Global Gases for Pharmaceutical and Biotechnology Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Gases for Pharmaceutical and Biotechnology Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Gases for Pharmaceutical and Biotechnology Sales Volume Share by Type (2021-2032) Figure 16. Global Gases for Pharmaceutical and Biotechnology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Gases for Pharmaceutical and Biotechnology Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type (2021-2032) Figure 19. Laboratory Image Figure 20. Pharmaceutical and Biotechnology Companies Image Figure 21. Others Image Figure 22. Global Gases for Pharmaceutical and Biotechnology Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Gases for Pharmaceutical and Biotechnology Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Gases for Pharmaceutical and Biotechnology Sales Volume Share by Application (2021-2032) Figure 25. Global Gases for Pharmaceutical and Biotechnology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Gases for Pharmaceutical and Biotechnology Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application (2021-2032) Figure 28. Global Gases for Pharmaceutical and Biotechnology Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 29. Global Gases for Pharmaceutical and Biotechnology Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Gases for Pharmaceutical and Biotechnology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032) & (US$ Million) Figure 33. North America Gases for Pharmaceutical and Biotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Gases for Pharmaceutical and Biotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Gases for Pharmaceutical and Biotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032) & (US$ Million) Figure 39. South America Gases for Pharmaceutical and Biotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Gases for Pharmaceutical and Biotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Gases for Pharmaceutical and Biotechnology Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Gases for Pharmaceutical and Biotechnology Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Nitrogen
  • Carbon Dioxide
  • Oxygen
  • Others
Applications
  • Laboratory
  • Pharmaceutical and Biotechnology Companies
  • Others
Companies covered
  • Air Liquide
  • Taiyo Nippon Sanso
  • Messer Group
  • Matheson
  • Air Products
  • Coregas
  • Linde
  • SOL Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032)
  4. 1.2.2 Global Gases for Pharmaceutical and Biotechnology Sales Volume (2021-2032)
  5. 1.2.3 Global Gases for Pharmaceutical and Biotechnology Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gases for Pharmaceutical and Biotechnology Market Dynamics
  1. 2.1 Gases for Pharmaceutical and Biotechnology Industry Trends
  2. 2.2 Gases for Pharmaceutical and Biotechnology Industry Drivers
  3. 2.3 Gases for Pharmaceutical and Biotechnology Industry Opportunities and Challenges
  4. 2.4 Gases for Pharmaceutical and Biotechnology Industry Restraints
3 Gases for Pharmaceutical and Biotechnology Market by Company
  1. 3.1 Global Gases for Pharmaceutical and Biotechnology Company Revenue Ranking in 2025
  2. 3.2 Global Gases for Pharmaceutical and Biotechnology Revenue by Company (2021-2026)
  3. 3.3 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Company (2021-2026)
  4. 3.4 Global Gases for Pharmaceutical and Biotechnology Average Price by Company (2021-2026)
  5. 3.5 Global Gases for Pharmaceutical and Biotechnology Company Ranking (2024-2026)
  6. 3.6 Global Gases for Pharmaceutical and Biotechnology Company Manufacturing Base and Headquarters
  7. 3.7 Global Gases for Pharmaceutical and Biotechnology Company Product Type and Application
  8. 3.8 Global Gases for Pharmaceutical and Biotechnology Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gases for Pharmaceutical and Biotechnology Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gases for Pharmaceutical and Biotechnology Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gases for Pharmaceutical and Biotechnology Market by Type
  1. 4.1 Gases for Pharmaceutical and Biotechnology Type Introduction
  2. 4.1.1 Nitrogen
  3. 4.1.2 Carbon Dioxide
  4. 4.1.3 Oxygen
  5. 4.1.4 Others
  6. 4.2 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Type
  7. 4.2.1 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Gases for Pharmaceutical and Biotechnology Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Gases for Pharmaceutical and Biotechnology Sales Value by Type
  11. 4.3.1 Global Gases for Pharmaceutical and Biotechnology Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Gases for Pharmaceutical and Biotechnology Sales Value by Type (2021-2032)
  13. 4.3.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type (2021-2032)
5 Gases for Pharmaceutical and Biotechnology Market by Application
  1. 5.1 Gases for Pharmaceutical and Biotechnology Application Introduction
  2. 5.1.1 Laboratory
  3. 5.1.2 Pharmaceutical and Biotechnology Companies
  4. 5.1.3 Others
  5. 5.2 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Application
  6. 5.2.1 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Gases for Pharmaceutical and Biotechnology Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Gases for Pharmaceutical and Biotechnology Sales Value by Application
  10. 5.3.1 Global Gases for Pharmaceutical and Biotechnology Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gases for Pharmaceutical and Biotechnology Sales Value by Application (2021-2032)
  12. 5.3.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application (2021-2032)
6 Gases for Pharmaceutical and Biotechnology Regional Sales and Value Analysis
  1. 6.1 Global Gases for Pharmaceutical and Biotechnology Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gases for Pharmaceutical and Biotechnology Sales by Region (2021-2032)
  3. 6.2.1 Global Gases for Pharmaceutical and Biotechnology Sales by Region: 2021-2026
  4. 6.2.2 Global Gases for Pharmaceutical and Biotechnology Sales by Region (2027-2032)
  5. 6.3 Global Gases for Pharmaceutical and Biotechnology Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gases for Pharmaceutical and Biotechnology Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gases for Pharmaceutical and Biotechnology Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gases for Pharmaceutical and Biotechnology Sales Value by Region (2027-2032)
  9. 6.5 Global Gases for Pharmaceutical and Biotechnology Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032)
  12. 6.6.2 North America Gases for Pharmaceutical and Biotechnology Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032)
  15. 6.7.2 Europe Gases for Pharmaceutical and Biotechnology Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gases for Pharmaceutical and Biotechnology Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032)
  21. 6.9.2 South America Gases for Pharmaceutical and Biotechnology Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gases for Pharmaceutical and Biotechnology Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gases for Pharmaceutical and Biotechnology Sales Value Share by Country, 2025 VS 2032
7 Gases for Pharmaceutical and Biotechnology Country-level Sales and Value Analysis
  1. 7.1 Global Gases for Pharmaceutical and Biotechnology Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gases for Pharmaceutical and Biotechnology Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gases for Pharmaceutical and Biotechnology Sales by Country (2021-2032)
  4. 7.3.1 Global Gases for Pharmaceutical and Biotechnology Sales by Country (2021-2026)
  5. 7.3.2 Global Gases for Pharmaceutical and Biotechnology Sales by Country (2027-2032)
  6. 7.4 Global Gases for Pharmaceutical and Biotechnology Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gases for Pharmaceutical and Biotechnology Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gases for Pharmaceutical and Biotechnology Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Air Liquide
  2. 8.1.1 Air Liquide Company Information
  3. 8.1.2 Air Liquide Business Overview
  4. 8.1.3 Air Liquide Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Air Liquide Gases for Pharmaceutical and Biotechnology Product Portfolio
  6. 8.1.5 Air Liquide Recent Developments
  7. 8.2 Taiyo Nippon Sanso
  8. 8.2.1 Taiyo Nippon Sanso Company Information
  9. 8.2.2 Taiyo Nippon Sanso Business Overview
  10. 8.2.3 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Product Portfolio
  12. 8.2.5 Taiyo Nippon Sanso Recent Developments
  13. 8.3 Messer Group
  14. 8.3.1 Messer Group Company Information
  15. 8.3.2 Messer Group Business Overview
  16. 8.3.3 Messer Group Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Messer Group Gases for Pharmaceutical and Biotechnology Product Portfolio
  18. 8.3.5 Messer Group Recent Developments
  19. 8.4 Matheson
  20. 8.4.1 Matheson Company Information
  21. 8.4.2 Matheson Business Overview
  22. 8.4.3 Matheson Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Matheson Gases for Pharmaceutical and Biotechnology Product Portfolio
  24. 8.4.5 Matheson Recent Developments
  25. 8.5 Air Products
  26. 8.5.1 Air Products Company Information
  27. 8.5.2 Air Products Business Overview
  28. 8.5.3 Air Products Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Air Products Gases for Pharmaceutical and Biotechnology Product Portfolio
  30. 8.5.5 Air Products Recent Developments
  31. 8.6 Coregas
  32. 8.6.1 Coregas Company Information
  33. 8.6.2 Coregas Business Overview
  34. 8.6.3 Coregas Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Coregas Gases for Pharmaceutical and Biotechnology Product Portfolio
  36. 8.6.5 Coregas Recent Developments
  37. 8.7 Linde
  38. 8.7.1 Linde Company Information
  39. 8.7.2 Linde Business Overview
  40. 8.7.3 Linde Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Linde Gases for Pharmaceutical and Biotechnology Product Portfolio
  42. 8.7.5 Linde Recent Developments
  43. 8.8 SOL Group
  44. 8.8.1 SOL Group Company Information
  45. 8.8.2 SOL Group Business Overview
  46. 8.8.3 SOL Group Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 SOL Group Gases for Pharmaceutical and Biotechnology Product Portfolio
  48. 8.8.5 SOL Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gases for Pharmaceutical and Biotechnology Value Chain Analysis
  2. 9.1.1 Gases for Pharmaceutical and Biotechnology Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gases for Pharmaceutical and Biotechnology Sales Mode & Process
  6. 9.2 Gases for Pharmaceutical and Biotechnology Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gases for Pharmaceutical and Biotechnology Distributors
  9. 9.2.3 Gases for Pharmaceutical and Biotechnology Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst